Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Maravai LifeSciences Holdings Inc MRVI

Technology Scientific & Technical Instruments
Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enable the development of drug therapies, diagnostics and vaccines and to support research on human diseases. Its companies provide products and services in the fields of nucleic acid synthesis and biologics safety testing to various biopharmaceutical, vaccine, diagnostics, and cell and gene... see more

Recent & Breaking News (NDAQ:MRVI)

Maravai LifeSciences Reports First Quarter 2022 Financial Results

GlobeNewswire May 5, 2022

Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 5, 2022

GlobeNewswire April 21, 2022

BIO-TECHNE AND CYGNUS TECHNOLOGIES, PART OF MARAVAI LIFESCIENCES, INTRODUCE NEW SIMPLE PLEX HEK 293 HCP 3G IMMUNOASSAY

PR Newswire April 12, 2022

Maravai LifeSciences Announces March 2022 Investor Conference Schedule

GlobeNewswire March 9, 2022

Maravai LifeSciences Reports Fourth Quarter and Full Year 2021 Financial Results and Updates 2022 Financial Guidance

GlobeNewswire February 23, 2022

Maravai LifeSciences Acquires MyChem, a Leader in Proprietary Ultra-Pure Nucleotides

GlobeNewswire January 28, 2022

Maravai LifeSciences Announces Upcoming Investor Events

GlobeNewswire January 25, 2022

Maravai LifeSciences Announces Debt Repricing

GlobeNewswire January 20, 2022

Maravai LifeSciences Announces Registration and Webcast Information for Upcoming R&D Day, to be Held on January 28, 2022

GlobeNewswire January 5, 2022

Dr. Jessica Hopfield Appointed to Berkeley Lights Board of Directors

GlobeNewswire December 20, 2021

Maravai LifeSciences Added to the Nasdaq Biotechnology Index

GlobeNewswire December 14, 2021

Maravai LifeSciences Announces Establishment of New Charitable Foundation

GlobeNewswire December 9, 2021

Direxion Launches mRNA ETF (MSGR)

PR Newswire December 9, 2021

Maravai LifeSciences Reports Third Quarter Financial Results, Updates 2021 Financial Guidance and Provides Preliminary Revenue Guidance For 2022

GlobeNewswire November 10, 2021

New England Biolabs® releases next generation HiScribe(TM) in vitro transcription kit, incorporating TriLink® Biotechnologies' CleanCap® technology for mRNA synthesis

PR Newswire November 8, 2021

Maravai LifeSciences Announces November 2021 Investor Conference Schedule

GlobeNewswire November 2, 2021

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 10, 2021

GlobeNewswire October 13, 2021

Maravai LifeSciences Expands its Intellectual Property Portfolio with European Patent

GlobeNewswire October 7, 2021

TriLink BioTechnologies® Extends EyeGene Partnership for COVID-19 Vaccine Development in South Korea

GlobeNewswire October 4, 2021

Maravai LifeSciences Announces Pricing of Secondary Offering of Class A Common Stock by Selling Stockholders

GlobeNewswire September 10, 2021